Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma

ABSTRACT: Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma

PROVIDER: PRJNA732694 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma

Project description:Radiation-induced high-grade gliomas (RIGs) are an incurable late complication of cranial radiation therapy. We performed DNA methylation profiling, RNA-seq, and DNA sequencing on 32 RIG tumors and an in vitro drug screen in two RIG cell lines. We report that based on DNA methylation, RIGs cluster primarily with the pediatric receptor tyrosine kinase I high-grade glioma subtype. Common copy-number alterations include Chromosome (Ch.) 1p loss/1q gain, and Ch. 13q and Ch. 14q loss; focal alterations include PDGFRA and CDK4 gain and CDKN2A and BCOR loss. Transcriptomically, RIGs comprise a stem-like subgroup with lesser mutation burden and Ch. 1p loss and a pro-inflammatory subgroup with greater mutation burden and depleted DNA repair gene expression. Chromothripsis in several RIG samples is associated with extrachromosomal circular DNA-mediated amplification of PDGFRA and CDK4. Drug screening suggests microtubule inhibitors/stabilizers, DNA-damaging agents, MEK inhibition, and, in the inflammatory subgroup, proteasome inhibitors as potentially effective therapies.

2021-05-27 | GSE175543 | GEO

PRMT5 promotes growth of pediatric high grade glioma.

Project description:PRMT5 promotes growth of pediatric high grade glioma.

| PRJNA1087354 | ENA

Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high grade glioma [bulkRNA-seq]

Project description:Bulk RNA-Seq of pediatric high-grade glioma patient samples

2023-11-03 | GSE231858 | GEO

Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high grade glioma [scRNA-seq]

Project description:Single-cell RNA-Seq was conducted on 19 pediatric high-grade glioma patient samples to study tumor heterogeneity and tumor/immune cell interaction.

2023-11-03 | GSE231859 | GEO

Effect of disulfiram treatment on pediatric high grade glioma

Project description:Effect of disulfiram treatment on pediatric high grade glioma

| PRJNA577636 | ENA

Single-cell ATAC-Seq of pediatric high-grade glioma

Project description:Single-cell ATAC-Seq of pediatric high-grade glioma

| PRJNA687013 | ENA

Gene expression (RNA-Seq) in pediatric high-grade glioma cell lines treated with selinexor and vehicle

Project description:Cultured pediatric high-grade glioma cell lines (SU-DIPG-IV, HSJD-DIPG-007, HSJD-GBM-001,BT 245 (RRID:CVCL_IP13)) were treated with selinexor (Karyopharm Therapeutics) at 5xIC50 for 16 hours or vehicle (0.1% DMSO) followed by bulk RNA-Seq

2020-01-06 | GSE137702 | GEO

G207 and PVSRIPO treatment of medulloblastoma and pediatric high grade glioma

Project description:HSV G207 and polio:rhinovirus PVSRIPO are two different viral immunotherapies used to treat malignant brain tumors in children. While some patients experience durable survival with these viral immunotherapies, many children have no response. The purpose of this work is to explore these viral immunotherapies in pediatric high grade glioma (pHGG) and medulloblastoma in order to elucidate how tumor response to treatment and to identify putative biomarkers of response and therapeutic targets.

2024-01-31 | GSE233949 | GEO

Single-cell ATAC-Seq of recurrent pediatric high-grade glioma

Project description:Single-cell ATAC-Seq of recurrent pediatric high-grade glioma

| PRJNA687016 | ENA

PRMT5 promotes growth of pediatric high grade glioma [ChIP-seq]

Project description:PRMT5 promotes growth of pediatric high grade glioma [ChIP-seq]

| PRJNA1087361 | ENA